Browse studies

Find your next paid study

363 recruiting studies matching your filters

Lung and Heart Function Across Decades of Life in Healthy Population

The main objective of this study is to develop baseline "normal" reference values of both lung and heart function for healthy adults within the age range relev…

Estimated

~$10 – $675

University of California, San FranciscoNCT07641413

Phase 4

Nebulizer Versus Handheld Maintenance Therapy for Patients With COPD

Multi-site, randomized controlled trial to determine whether patients who report NO symptomatic benefit with their maintenance hand-held inhaler(s), benefit up…

COPD (Chronic Obstructive Pulmonary Disease)Chronic Obstructive Pulmonary Disease (COPD)

Estimated

~$10 – $6,250

COPD FoundationNCT07816835

Phase 3

A Phase 3, Multicenter, Randomized, Double-Blind Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Mosliciguat in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease

A Phase 3, Multicenter, Randomized, Double-Blind Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Mosliciguat in Participants with Pulmo…

Pulmonary HypertensionInterstitial Lung DiseaseVascular Diseases+2 more

Estimated

~$10 – $8,750

Pulmovant, Inc.NCT07816185

Observational

Feasibility and Acceptability of a Mobile Application "SUPPORT-T" to Increase Equitable Access to Palliative Care in Patients With Progressive Pulmonary Fibrosis (PPF) and Their Caregivers

This pilot randomized controlled trial evaluates the feasibility, acceptability, and accessibility of SUPPORT-T, a digitally delivered palliative care interven…

Progressive Pulmonary FibrosisInterstitial Lung Disease

Estimated

~$10 – $6,250

Medical University of South CarolinaNCT07269262

Phase 1

Phase 1b/2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study Assessing the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of HS235 Added to Background Treatment in Adults With PAH

Phase 1b/2 Study of HS235 Assessing the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of the Activin Signaling Inhibitor HS235 Added to Background T…

Pulmonary Arterial Hypertension

Estimated

~$10 – $8,750

35Pharma IncNCT07143448

Observational

Role of n On-contrast Chest CT (NCCT) Based CT V: Q in Patients With Acute Pulmonary Embolism (aPE)

We are doing the research to see if a CT scan without the dye can help find pulmonary emboli. If you agree to join the study, you will be asked to sign this co…

Pulmonary Embolism (Diagnosis)Pulmonary Embolism Acute

Estimated

~$10 – $6,250

Massachusetts General HospitalNCT07527117

Observational

The PERSEVERE Study

Randomized Controlled Trial of High-Risk Pulmonary Embolism Comparing FlowTriever System vs. Standard of Care

Pulmonary EmbolismPulmonary Thromboembolism

Estimated

~$10 – $7,500

Inari MedicalNCT06588634

Role of Genetic Factors in the Pathogenesis of Lung Disease

This study is designed to evaluate the genetics involved in the development of lung disease by surveying genes involved in the process of breathing and examini…

Cystic FibrosisPulmonary FibrosisTuberous Sclerosis+2 more

Estimated

~$10 – $675

National Heart, Lung, and Blood Institute (NHLBI)NCT00001532

Phase 2

A Multicentre, Parallel-group, Phase IIb, Randomised, Double-blind, Placebo-controlled, 3-Arm, 24-Week Study to Evaluate the Efficacy and Safety of AZD6793 Tablets in Adult Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (PRESTO)

This Phase IIb dose-ranging study will evaluate the efficacy and safety of 2 different doses of AZD6793 compared with placebo tablets in participants with mode…

Chronic Obstructive Pulmonary Disease (COPD)

Estimated

~$10 – $7,500

AstraZenecaNCT07082738

Phase 1

The Safety and Toxicity of Inhaled Ciclesonide (i.e., Alvesco) in Preterm Infants at Risk for Developing Bronchopulmonary Dysplasia

Our overall objective is to conduct a safety study with inhaled ciclesonide to evaluate known glucocorticoids (sGC)-related acute and intermediate toxic effect…

Bronchopulmonary Dysplasia

Estimated

~$10 – $7,500

Venkatesh SampathNCT06589245

An Observational, Non-Interventional Study Supporting Validation of eVO2peak Using Results in Patients Receiving Standard of Care Cardiopulmonary Exercise Tests (CPET)

In this study, the hypothesis being explored is that peak VO2 and potentially other CPET parameters can be accurately estimated from biosignals (namely, motion…

Using Community Health Workers to Support Rural Care Partners of Seriously Ill Older Veterans

The investigators aim to support care partner's well-being and satisfaction with VA care and decrease their work burden by offering extra support from a traine…

DementiaCancerRenal Disease+1 more

Estimated

~$10 – $5,625

VA Office of Research and DevelopmentNCT06963970